Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin.

Naruse H, Nagashima Y, Maekawa R, Etoh T, Hida A, Shimizu J, Kaida K, Shiio Y.

J Clin Neurosci. 2013 Nov;20(11):1618-9. doi: 10.1016/j.jocn.2012.12.016. Epub 2013 Jul 29.

PMID:
23906523
2.

Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.

Mori M, Imagawa T, Hara R, Kikuchi M, Hara T, Nozawa T, Miyamae T, Yokota S.

J Rheumatol. 2012 Apr;39(4):864-7. doi: 10.3899/jrheum.110877. Epub 2012 Feb 15.

PMID:
22337241
3.

Weight gain and tumour necrosis factor-alpha inhibitors in patients with psoriasis.

Tan E, Baker C, Foley P.

Australas J Dermatol. 2013 Nov;54(4):259-63. doi: 10.1111/ajd.12044.

PMID:
24164178
4.
5.

Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy.

Lozeron P, Denier C, Lacroix C, Adams D.

Arch Neurol. 2009 Apr;66(4):490-7. doi: 10.1001/archneurol.2009.11.

PMID:
19364934
6.

Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.

Broge T, Nguyen N, Sacks A, Davis M.

Inflamm Bowel Dis. 2013 Apr;19(5):E75-7. doi: 10.1097/MIB.0b013e3182802c93. No abstract available.

PMID:
23435403
7.

Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis.

Hooper DR, Tarnopolsky MA, Baker SK.

Muscle Nerve. 2008 Oct;38(4):1318-25. doi: 10.1002/mus.21051.

PMID:
18671292
8.

[Infliximab. Role in the treatment of psoriasis].

Mössner R, Reich K.

Hautarzt. 2005 Sep;56(9):831-2, 834-8. Review. German.

PMID:
16133635
9.

Inflammatory neuropathies--pathogenesis and the role of intravenous immune globulin.

van der Meché FG, van Doorn PA, Jacobs BC.

J Clin Immunol. 1995 Nov;15(6 Suppl):63S-69S. Review.

PMID:
8613494
10.

Osteomyelitis occurring during infliximab treatment of severe psoriasis.

Sri JC, Tsai CL, Deng A, Gaspari AA.

J Drugs Dermatol. 2007 Feb;6(2):207-10.

PMID:
17373180
11.

Infliximab for psoriasis.

Gottlieb AB.

J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S112-7. Review.

PMID:
12894134
12.

Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.

Son MB, Gauvreau K, Burns JC, Corinaldesi E, Tremoulet AH, Watson VE, Baker A, Fulton DR, Sundel RP, Newburger JW.

J Pediatr. 2011 Apr;158(4):644-649.e1. doi: 10.1016/j.jpeds.2010.10.012. Epub 2010 Dec 3.

PMID:
21129756
13.

Infliximab-induced psoriasis during therapy for Crohn's disease.

Steinwurz F, Denadai R, Saad-Hossne R, Queiroz ML, Teixeira FV, Romiti R.

J Crohns Colitis. 2012 Jun;6(5):610-6. doi: 10.1016/j.crohns.2011.12.007. Epub 2012 Jan 26.

PMID:
22398095
14.

Worsening of vitiligo and onset of new psoriasiform dermatitis following treatment with infliximab.

Alghamdi KM, Khurrum H, Rikabi A.

J Cutan Med Surg. 2011 Sep-Oct;15(5):280-4.

PMID:
21962188
15.

Psoriasis triggered by infliximab in a patient with Behçet's disease.

Kawazoe Y, Sugita S, Yamada Y, Akino A, Miura K, Mochizuki M.

Jpn J Ophthalmol. 2013 Jan;57(1):95-7. doi: 10.1007/s10384-012-0198-4. Epub 2012 Oct 23.

PMID:
23090423
16.

Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Tektonidou MG, Serelis J, Skopouli FN.

Clin Rheumatol. 2007 Feb;26(2):258-60. Epub 2006 Jul 6.

PMID:
16683176
17.

[Neurological symptoms following infusion of infliximab].

Bebe AC, Harboe KM, Nøjgaard C.

Ugeskr Laeger. 2012 Oct 1;174(40):2388-90. Danish.

PMID:
23031302
18.

Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis.

Ahmed Z, Powell R, Llewelyn G, Anstey A.

BMJ Case Rep. 2011 Dec 1;2011. pii: bcr0820114674. doi: 10.1136/bcr.08.2011.4674.

19.

Infliximab in psoriasis and psoriatic arthritis.

Papoutsaki M, Osório F, Morais P, Torres T, Magina S, Chimenti S, Costanzo A.

BioDrugs. 2013 Jan;27 Suppl 1:13-23. doi: 10.1007/BF03325638. Review.

PMID:
23990278
20.

Cutaneous adverse reaction to infliximab: report of psoriasis developing in 3 patients.

Severs GA, Lawlor TH, Purcell SM, Adler DJ, Thompson R.

Cutis. 2007 Sep;80(3):231-7.

PMID:
17956013
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk